MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..

Zantac 75 Efferdose

Company: GlaxoSmithKline
Approval Status: Approved March 1998
Treatment for: heartburn
Areas: Gastrointestinal

| General Information |

General Information

Zantac 75 Efferdose has been approved for the treatment of heartburn. It is the first over-the-counter effervescent H2 antagonist.

< back to top

Zantac 75 Efferdose Drug Information

The Zantac 75 Efferdose drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2016 All rights reserved.